Two Sigma Advisers’s ProKidney PROK Stock Holding History

Two Sigma Advisers’s Portfolio PROK Stock Details PROK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,900	Closed	-$24.4K	–	1621
2025 Q4	$24.4K	Buy	+10,900	New	+$28.7K	﹤0.01%	2307

Other funds holding PROK

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

AGP

Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Advisers's PROK Position: Q1 2026 in Review

Two Sigma Advisers sold out of ProKidney (PROK) in Q1 2026, closing a stake of 10,900 shares — an estimated $24.4K sold.

Two Sigma Advisers first reported a position in PROK in Q4 2025 and held it in 1 quarter. The position peaked at $24.4K in Q4 2025. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

Two Sigma Advisers reported no remaining ProKidney position as of Q1 2026 after selling out during the quarter.
Two Sigma Advisers sold 10,900 ProKidney shares in Q1 2026, an estimated $24.4K.
Two Sigma Advisers first reported a position in ProKidney in Q4 2025 and held it in 1 quarter.
Two Sigma Advisers's ProKidney position peaked at $24.4K in Q4 2025.
71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.